Medicine guide

XOSPATA

As listed in the register: XOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

40 mg · comprimido recubierto con película

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Gilteritinib
Made by
Astellas Pharma Europe B.V.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01EX13

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byAstellas Pharma Europe B.V.
Active substanceGilteritinib
Used inCancer treatments and immune-system medicines
Strength40 mg
Formcomprimido recubierto con película
ClassificationL01EX13 · Cancer treatments and immune-system medicines
Routevía oral
MarketedYes, according to the register
Orphan medicineYes — designated for a rare disease, according to the register
DrivingThe regulator flags that this medicine can affect the ability to drive.
Name in the registerXOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Nº Registro1191399001

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.